SM
Sabari Mondal
About Sabari Mondal
Data last updated:
Sabari Mondal is an Additional Director at Lorfan Pharma Private Limited (since 2026). Lorfan Pharma Private Limited reported revenue of ₹27.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lorfan Pharma Private Limited U47721WB2024PTC267243 | Additional Director | 17 Jan 2026 | ₹27.1 Lakh (FY 2025) | Active |
Board colleagues of Sabari Mondal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manali Ghosh | 10449835 | Lorfan Pharma Private Limited | Director |
| Rina Nag | 10449836 | Lorfan Pharma Private Limited | Director |
| Soma Banerjee | 10601554 | Lorfan Pharma Private Limited | Additional Director |
| Suparna Nag Rajak | 10449837 | Lorfan Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sabari Mondal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sabari Mondal
Sabari Mondal currently holds 1 directorship: Lorfan Pharma Private Limited (Additional Director, since 17 Jan 2026, revenue ₹27.1 Lakh (FY 2025)).
Sabari Mondal was first appointed on 17 Jan 2026 as Additional Director at Lorfan Pharma Private Limited.
The current boards of Sabari Mondal's companies include Manali Ghosh (Lorfan Pharma Private Limited), Rina Nag (Lorfan Pharma Private Limited), Soma Banerjee (Lorfan Pharma Private Limited), Suparna Nag Rajak (Lorfan Pharma Private Limited).